Masashi Nakaura
Nessuna posizione attualmente
Profilo
Masashi Nakaura served as Chief Executive Officer at Taisho Pharmaceuticals Philippines, Inc., Director-Singapore, Malaysia & Indonesia Business at PT Bristol Myers Squibb Indonesia, General Director & Director at DHG Pharmaceutical JSC, and Operational Director at PT Taisho Pharmaceutical Indonesia.
Nakaura received an undergraduate degree from Sophia University in 1981.
Precedenti posizioni note di Masashi Nakaura
| Società | Posizione | Fine |
|---|---|---|
| DHG PHARMACEUTICAL | Amministratore Delegato | - |
PT Bristol Myers Squibb Indonesia
 PT Bristol Myers Squibb Indonesia Pharmaceuticals: MajorHealth Technology The Group's principal activities are manufacturing and selling pharmaceutical and health care products. The products comprise of ethical products, over-the-counter products and oncology products. Brands include, Counterpain, Counterpain Cool, Tempra, Tempra Forte, Baraclude, Taxol and Sprycel. The Group's plant is located in Cilangkap, Depok. | Corporate Officer/Principal | - |
| Taisho Pharmaceuticals Philippines, Inc. | Amministratore Delegato | - |
| TAISHO PHARMACEUTICAL INDONESIA TBK PT | Direttore operativo | - |
Formazione di Masashi Nakaura
| Sophia University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DHG PHARMACEUTICAL | Health Technology |
| Aziende private | 3 |
|---|---|
PT Taisho Pharmaceutical Indonesia
 PT Taisho Pharmaceutical Indonesia Pharmaceuticals: MajorHealth Technology PT Taisho Pharmaceutical Indonesia engages in the development, registration, process, production and sale of chemical, pharmaceutical, and health care products. Its products include Tempra, Analgesic Balm and Theragran-M. The company was founded on July 8, 1970 and is headquartered in Jakarta, Indonesia. | Health Technology |
PT Bristol Myers Squibb Indonesia
PT Bristol Myers Squibb Indonesia Pharmaceuticals: MajorHealth Technology The Group's principal activities are manufacturing and selling pharmaceutical and health care products. The products comprise of ethical products, over-the-counter products and oncology products. Brands include, Counterpain, Counterpain Cool, Tempra, Tempra Forte, Baraclude, Taxol and Sprycel. The Group's plant is located in Cilangkap, Depok. | Health Technology |
| Taisho Pharmaceuticals Philippines, Inc. |
- Borsa valori
- Insiders
- Masashi Nakaura
